How much funding has OvaScience raised?

OvaScience has raised $150.8M in total funding, most recently a Corporate Round.

Who are OvaScience's investors?

OvaScience's investors include General Catalyst, Bessemer VP, Longwood Fund, GreatPoint Ventures, New Enterprise Associates, Frazier Healthcare.

When was OvaScience founded?

OvaScience was founded in 2011.

Where is OvaScience headquartered?

OvaScience is headquartered in Cambridge, Massachusetts, United States.

What industry is OvaScience in?

OvaScience operates in Biotech, Healthcare.

How many employees does OvaScience have?

OvaScience has 51-200 employees.

OvaScience

Closed

Discovering new fertility treatment options.

Public · Cambridge, United States · Founded 2011 · $150.8M raised

Biotech

Healthcare

Headquarters: Cambridge, Massachusetts
Employees: 51–200
Founded: 2011
Business Model: B2C
Website: ovascience.com

Total Funding: $150.8M
Last Round: $50.0M Corporate RoundDec 2018
Rounds: 5
Type: Public

About

OvaScience was a publicly traded biotechnology company focused on female infertility, applying novel science around egg precursor cells (EggPCSM cells) to improve egg quality and IVF outcomes. Founded in 2011 and based in Cambridge and later Waltham, Massachusetts, the company completed a reverse merger with Millendo Therapeutics in December 2018, ceasing to operate as OvaScience. The domain now redirects to an unrelated site.

Summary

OvaScience is a Biotech company based in Cambridge, United States, founded in 2011. It has raised $150.8M in total across 5 rounds, most recently a $50.0M Corporate Round round in Dec 2018. Investors include General Catalyst, Bessemer VP and Longwood Fund.

LinkedIn X (Twitter)